Khan Irfan A, Small Ilan, Sutton Ryan M, Goh Graham S, Sherman Matthew B, Mazur Donald W, Fillingham Yale A
Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, PA.
J Arthroplasty. 2022 Jun;37(6):1059-1063.e1. doi: 10.1016/j.arth.2022.02.027. Epub 2022 Feb 19.
While injections within 90 days prior to total knee arthroplasty (TKA) are associated with an increased risk of periprosthetic joint infection (PJI), there is a paucity of literature regarding the impact of cumulative injections on PJI risk. This study was conducted to assess the association between cumulative corticosteroid and hyaluronic acid (HA) injections and PJI risk following TKA.
This retrospective study using an injection database included patients undergoing TKA with a minimum 1-year follow-up from 2015 to 2020. Patients with injections within 90 days prior to surgery were excluded. The sum of corticosteroid and HA injections within five years prior to TKA was recorded. The primary outcome was PJI within 90 days following TKA. Area under the curve (AUC) values were calculated for a cumulative number of injections.
648 knees with no injections and 672 knees with injections prior to TKA were included, among whom 243 received corticosteroids, 151 received HA, and 278 received both. No significant differences in early PJI rates existed between patients who received injections (0.60%) or not (0.93%) (P = .541). No significant differences existed in early PJI rates between patients injected with corticosteroids (0.82%), HA (0.66%), or both (0.36%) (P = .832). No cutoff number of injections was predictive for PJI.
A cumulative amount of steroid or HA injections, if given more than 90 days prior to TKA, does not appear to increase the risk of PJI within 90 days postoperatively. Multiple intraarticular corticosteroid injections and HA injections may be safely administered before TKA, without increased risk for early PJI.
虽然全膝关节置换术(TKA)前90天内注射与假体周围关节感染(PJI)风险增加有关,但关于累积注射对PJI风险影响的文献较少。本研究旨在评估TKA后累积皮质类固醇和透明质酸(HA)注射与PJI风险之间的关联。
这项回顾性研究使用注射数据库,纳入了2015年至2020年接受TKA且至少随访1年的患者。排除术前90天内有注射史的患者。记录TKA前五年内皮质类固醇和HA注射的总和。主要结局是TKA后90天内发生的PJI。计算累积注射次数的曲线下面积(AUC)值。
纳入648例TKA前未注射的膝关节和672例TKA前有注射史的膝关节,其中243例接受皮质类固醇注射,151例接受HA注射,278例接受两种注射。接受注射的患者(0.60%)和未接受注射的患者(0.93%)的早期PJI发生率无显著差异(P = 0.541)。注射皮质类固醇(0.82%)、HA(0.66%)或两者(0.36%)的患者早期PJI发生率无显著差异(P = 0.832)。没有注射次数的临界值可预测PJI。
如果在TKA前90天以上进行累积的类固醇或HA注射,似乎不会增加术后90天内发生PJI的风险。在TKA前可安全地多次进行关节内皮质类固醇注射和HA注射,而不会增加早期PJI的风险。